JAMA Psychiatry

Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness

By Roger S. McIntyre, Yanli Zhang-James, Angela T.H. Kwan

Cohort study of 1,528,230 peopleInterventions

4 years, multicentre

The paper

Roger S. McIntyre, Yanli Zhang-James, Angela T.H. Kwan

University of Toronto

JAMA Psychiatry, 26 Aug 2026

doi.org/10.1001/jamapsychiatry.2026.2574 PubMed 42647034

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Cardiology and Therapy4 Oct 2026
Low-carb telemedicine links to fewer cardiovascular events
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk